Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2013 Oct 28:2013:921819.
doi: 10.1155/2013/921819. eCollection 2013.

Association of psoriasis severity with serum prolactin, thyroid hormones, and cortisol before and after treatment

Affiliations
Controlled Clinical Trial

Association of psoriasis severity with serum prolactin, thyroid hormones, and cortisol before and after treatment

Reza M Robati et al. ScientificWorldJournal. .

Abstract

Background: Prolactin (PRL) level is proposed to be associated with the severity of psoriasis although the previous studies reported different results.

Objective: To find the association between PRL levels and severity of psoriasis before and after treatment. In addition, we aimed to find a difference in prolactin, thyroid stimulating hormone (TSH), thyroid hormones (T3 and T4), and cortisol levels between patients with psoriasis and normal controls.

Methods: First, the levels of hormones were measured in 30 patients with psoriasis and 30 matched controls. The severity was assessed by psoriasis area and severity index (PASI). Then, patients were treated, and PASI was assessed every week until achieving PASI-75 response. At this time, the hormones were measured again and compared to the baseline.

Results: No statistical significant difference was observed in the mean PRL, T3, T4, TSH, and cortisol levels between cases and controls. Comparing to the baseline, a significant decrease in PRL levels and a significant increase in T3 and serum cortisol levels were observed after treatment (P < 0.05), while the changes in other hormones were not significant.

Conclusion: After treatment, PRL significantly decreased, and T3 and cortisol levels significantly increased. No correlation between hormone levels and improvement of PASI score existed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The process of recruiting patients in the psoriasis group.

Similar articles

Cited by

References

    1. Ozawa M, Aiba S. Immunopathogenesis of psoriasis. Current Drug Targets: Inflammation and Allergy. 2004;3(2):137–144. - PubMed
    1. Wisnieski JJ. Urticarial vasculitis. Current Opinion in Rheumatology. 2000;12(1):24–31. - PubMed
    1. Asadullah K, Volk H-D, Sterry W. Novel immunotherapies for psoriasis. Trends in Immunology. 2002;23(1):47–53. - PubMed
    1. Langan EA, Griffiths CEM, Paus R. Exploring the role of prolactin in psoriasis. Archives of Dermatological Research. 2012;304(2):115–118. - PubMed
    1. Giasuddin ASM, El-Sherif AI, El-Ojali SI. Prolactin: does it have a role in the pathogenesis of psoriasis? Dermatology. 1998;197(2):119–122. - PubMed

Publication types

LinkOut - more resources